Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GCGR | P47871 | 3/20 | 0.48 |
| ▸ | SPHK2 | Q9NRA0 | 10/20 | 0.46 |
| ▸ | SPHK1 | Q9NYA1 | 8/20 | 0.43 |
| ▸ | ADCYAP1R1 | P41586 | 1/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5815660 | 1.00 | GCGR (0.48) | GCGRSPHK2SPHK1ADCYAP1R1CYP2D6 | |
| SCHEMBL1669458 | 0.75 | MEN1 (0.53) | SPHK2SPHK1ADCYAP1R1NPC1MAPT | |
| SCHEMBL6002241 | 0.72 | POLB (0.47) | MAPT | |
| SCHEMBL25620321 | 0.71 | ENPP2 (0.52) | MAPT | |
| SCHEMBL11302626 | 0.70 | ALDH1A1 (0.55) | NPC1MAPTRAB9A | |
| SCHEMBL17541218 | 0.70 | ALDH1A1 (0.55) | NPC1MAPTRAB9A | |
| SCHEMBL5809141 | 0.70 | GAA (0.65) | CYP2D6NPC1MAPTRAB9A | |
| SCHEMBL2474636 | 0.69 | SPHK2 (0.47) | SPHK2SPHK1NPC1MAPTRAB9A | |
| SCHEMBL22295829 | 0.68 | CYP1A2 (0.42) | MAPT | |
| SCHEMBL21211500 | 0.68 | GCGR (0.57) | GCGRSPHK2SPHK1CYP2D6NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2006136008-A1 | SALICYLIC ACID HYDRAZONES AS INHIBITORS OF THE ERK MAPKINASE PATHWAY AND FOR THE TREATMENT OF CANCER | UNIVERSITY HEALTH NETWORK (CA) | 2006-12-28 | — | — | WO | disclosed |